256
The potential applications of this breakthrough extend to the treatment of hereditary diseases such as cystic fibrosis, muscular dystrophy, and certain types of cancer. The improved accuracy of the CRISPR-Cas9 Prime system opens doors for therapeutic interventions that were previously considered too risky due to the potential for unintended genetic alterations.
